The role of matrix metalloproteinases and tissue inhibitors of metalloproteinases in systemic sclerosis;Rola metaloproteaz macierzy I tkankowych inhibitorów metaloproteaz w twardzlnie układowej

Przeglad Dermatologiczny

Volumn 90, Issue 5, 2003, Pages 373-381

  Bogaczewicz, Jarosław ^a   Chodorowska, Grazyna ^b   Krasowska, Dorota ^b  

^a AM ^*  (Poland)

^b Katedra i Klinika Dermatologii   (Poland)

Author keywords

Extracellular matrix; Matrix metalloproteinases; Systemic sclerosis; Tissue inhibitors of metalloproteinases

Indexed keywords

CYTOKINE; GROWTH FACTOR; HORMONE DERIVATIVE; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE;

CELL TRANSFORMATION; CONNECTIVE TISSUE; ENZYME ACTIVITY; ENZYME INHIBITION; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; REVIEW; SYSTEMIC SCLEROSIS; TRANSCRIPTION REGULATION;

EID: 0242404443     PISSN: 00332526     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Nagase H., Woessner J.F.Jr.: Matrix metalloproteinases. J Biol Chem 1999, 274, 21491-21494.
2. Saarialho-Kere U., Kerkela E., Jahkola T. i inni: Epilysin (MMP-28) expression is associated with cell proliferation during epithelial repair. J Invest Dermatol 2002, 119, 14-21.
3. Fini M.E., Cook J.R., Mohan R. i inni: Regulation of matrix metalloproteinase gene expression. [w:] Matrix metalloproteinases. W. Parks, R. Mechan (red.), Academic Press, San Diego, 1998, 300-356.
4. Janowska-Wieczorek A., Marquez L.A., Nabholtz J.M. i inni: Growth factors and cytokines upregulate gelatinase expression in bone marrow CD34(+) cells and their transmigration through reconstituted basement membrane. Blood 1999, 93, 3379-3390.
5. Pei D., Weiss S.J.: Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature 1995, 375, 244-247.
6. Strongin A.Y., Collier I., Bannikov G. i inni: Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloproteinase. J Biol Chem 1995, 270, 5331-5338.
7. Leco K.J., Khokha R., Pavloff N. i inni: Tissue inhibitor of metalloproteinase-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expresion in mouse cells and tissues. J Biol Chem 1994, 269, 9352-9360.
8. Stearns M.E., Rhim J., Wang M.: Interleukin 10 (IL- 10) inhibition of primary human prostate cell-induced angiogenesis: IL-10 stimulation of tissue inhibitor of metalloproteinase-1 and inhibition of matrix metalloproteinase (MMP)-2/MMP-9 secretion. Clin Cancer Res 1999, 5, 189-196.
9. Wick M., Burger C., Brusselbach S. i inni: A novel member of human tissue inhibitor of matrix metalloproteinases (TIMP) gene family is regulated during G1 progression, mitogenic stimulation, differentiation, and senescence. J Biol Chem 1994, 269, 18953-18960.
10. Wick M., Haronen R., Mumberg D. i inni: Structure of human TIMP-3 gene and its cell cycle-regulated promoter. Biochem J 1994, 311, 549-554.
11. Airola K., Ahonen M., Johansson N. i inni: Human TIMP-3 is expressed during fetal development, hair growth cycle and cancer progression. J Histochem Cytochem 1998, 46, 437-447.
12. Sollberg S., Mauch C., Eckes B.: The fibroblast in systemic sclerosis. Clin Dermatol 1994, 12, 279-285.
13. Varga J., Bashey R.I.: Regulation of connective tissue synthesis in systemic sclerosis. Int Rev Immunol 1995, 12, 187-199.
14. Peltonen J., KahSt'ri I., Uitto J.: Increased expression of type VI collagen genes in systemic sclerosis. Arthritis Rheum 1990, 33, 1829-1835.
15. Mauch C., Eckes B., Hunzelmann N. i inni: Control of fibrosis in systemic scleroderma. J Invest Dermatol 1993, 100, 92-96.
16. Kirk T.Z., Mark M.E., Chua Ch.C. i inni: Myofibroblasts from scleroderma skin synthesize elevated levels of collagen and tissue inhibitor of metalloproteinase (TIMP-1) with two forms of TIMP-1. J Biol Chem 1995, 270, 3423-3428.
17. Kuroda K., Shinaki H.: Gene expression of types I and III collagen, decorin, matrix metalloproteinases and tissue inhibitors of metalloproteinases in skin fibroblasts from patients with systemic sclerosis. Arch Dermatol Res 1997, 289, 567-572.
18. Marasini B., Casari S., Zeni O. i inni: Stromelysin promoter polymorphism is associated with systemic sclerosis Rheumatology 2001, 40, 475-476.
19. Johnson R.W., Reveille J.D., McNearney T. i inni: Lack of association of a functionally relevant single nucleotide polymorphism of matrix metalloproteinase-1 promoter with systemic sclerosis (scleroderma). Genes Immun 2001, 2, 273-275.
20. Takeda K., Hatamochi A., Ueki H. i inni: Decreased collagenase expression in cultured systemic sclerosis fibroblasts. J Invest Dermatol 1994, 103, 359-363.
21. Bou-Gharios G., Osman J., Black C. i inni: Excess matrix accumulation in scleroderma is caused partly by differential regulation of stromelysin and TIMP-1 synthesis. Clin Chim Acta 1994, 231, 69-78.
22. Fakhoury H., Hillarby M.C., Weiss J.B.: Increased gelatinase activity in systemic sclerosis dermal fibroblast cultures with unaltered gelatinase A mRNA expression. J Dermatol Sci 2002, 29, 62-69.
23. Scharffetter K., Wlaschek M., Hogg A. i inni: UVA irradiation induces collagenase in human dermal fibroblasts in vitro and in vivo. Arch Dermatol Res 1991, 283, 506-511.
24. Hofer A., Soyer H.P.: Oral psoralen-UV-A for systemic scleroderma. Arch Dermatol 1999, 135, 603-604.
25. Gruss C., Reed J.A., Altmeyer P. i inni: Induction of interstitial collagenase (MMP-1) by UVA-1 phototherapy in morphea fibroblasts. Lancet 1997, 350, 1295-1296.
26. Toubi E., Kessel A., Grushko G. i inni: The association of serum matrix metalloproteinases and their tissue inhibitor levels with scleroderma disease severity. Clin Exp Rheumatol 2002, 20, 221-224.
27. Kikuchi K., Kubo M., Hoashi T. i inni: Decreased MMP-9 activity in the serum of patients with diffuse cutaneous systemic sclerosis. Clin Exp Dermatol 2002, 27, 301-305.
28. Yazawa N., Kikuchi K., Ihn H. i inni: Serum levels of tissue inhibitor of metalloproteinases 2 in patients with systemic sclerosis. J Am Acad Dermatol 2000, 42, 70-75.
29. Mattila L., Airola K., Ahonen M. i inni: Activation of tissue inhibitor of metalloproteinase-3 (TIMP-3) mRNA expression in scleroderma skin fibroblasts. J Invest Dermatol 1998, 110, 416-421.
30. Wick M., Burger C., Brusselbach S. i inni: A novel member of human tissue inhibitor of matrix metalloproteinases (TIMP) gene family is regulated during G1 progression, mitogenic stimulation, differentiation, and senescence. J Biol Cem 1994, 269, 18953-18960.
31. Hayakawa T., Yamashita K., Tanzawa K. i inni: Growth-promoting activity of tissue inhibitor of metalloproteinase-1 (TIMP-1) for a wide range of cells. FEBS Lett 1992, 298, 29-32.
32. Hayakawa T., Yamashita K., Ohuchi E. i inni: Cell growth promoting activity of tissue inhibitor of metalloproteinase-2 (TIMP-2). J Cell Sci 1994, 107, 2373-2379.
33. Kikuchi K., Kadono T., Furue M. i inni: Tissue inhibitor of metalloproteinase 1 (TIMP-1) may be an autocrine growth factor in scleroderma fibroblasts. J Invest Dermatol 1995, 33, 973-978.
34. Young-Min S.A., Beeton C., Laughton R. i inni: Serum TIMP-1, TIMP-2, and MMP-1 in patients with systemic sclerosis, primary Raynaud's phenomenon, and in normal controls. Ann Rheum Dis 2001, 60, 846-851.
35. Dziankowska-Bartkowiak B., Waszczykowska E., Luczynska M. i inni: Serum levels of tissue inhibitor of metalloproteinases 2 in systemic sclerosis: a preliminary study. Med Sci Monit 2002, 8, 108-112.
36. Kikuchi K., Kubo M., Sato S. i inni: Serum tissue inhibitor of metalloproteinases in patients with systemic sclerosis. J Am Acad Dermatol 1995, 33, 973-978.